CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 
 

VIR's Revenue Growth by Quarter and Year

Vir Biotechnology Inc 's Revenue results by quarter and year




VIR Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 16.79 49.41 812.76 1.73
III Quarter September 2.64 374.56 103.62 1.93
II Quarter June 3.80 -40.63 177.07 66.99
I Quarter March 62.96 1,232.46 1.98 5.72
FY   86.19 1,615.80 1,095.43 76.37



VIR Revenue fourth quarter 2023 Y/Y Growth Comment
Vir Biotechnology Inc reported drop in Revenue in the fourth quarter 2023 by -66.03% to $ 16.79 millions, from the same quarter in 2022.
The fall in the fourth quarter 2023 Vir Biotechnology Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 10396.46%.

Looking into fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 39 other companies have achieved higher Revenue growth. While Vir Biotechnology Inc ' s Revenue meltdown of -66.03% ranks overall at the positon no. 2937 in the fourth quarter 2023.




VIR Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -66.03 % -93.92 % 46880.35 % -
III Quarter September -99.3 % 261.47 % 5268.91 % 37.86 %
II Quarter June - - 164.32 % -
I Quarter March -94.89 % 62145.45 % -65.38 % -
FY   -94.67 % 47.5 % 1334.37 % -

Financial Statements
Vir Biotechnology Inc 's fourth quarter 2023 Revenue $ 16.79 millions VIR's Income Statement
Vir Biotechnology Inc 's fourth quarter 2022 Revenue $ 49.41 millions Quarterly VIR's Income Statement
New: More VIR's historic Revenue Growth >>


VIR Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 535.87 % -86.81 % 684.37 % -10.36 %
III Quarter September -30.53 % - -41.48 % -97.12 %
II Quarter June -93.96 % - 8842.93 % 1071.15 %
I Quarter March 27.42 % 51.64 % 14.45 % -
FY (Year on Year)   -94.67 % 47.5 % 1334.37 % -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #40
Healthcare Sector #386
Overall #2937

Revenue Y/Y Growth Statistics
High Average Low
62271.41 % 10396.46 % -99.3 %
(Mar 31 2022)   (Sep 30 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #40
Healthcare Sector #386
Overall #2937
Revenue Y/Y Growth Statistics
High Average Low
62271.41 % 10396.46 % -99.3 %
(Mar 31 2022)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Vir Biotechnology Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
8860.93 % 837.39 % -97.12 %
(Jun 30 2021)  


VIR's IV. Quarter Q/Q Revenue Comment
Vir Biotechnology Inc achieved in the IV. Quarter 2023 below company average Revenue doubling of 535.87% quarter on quarter, to $ 16.79 millions.

Although the IV. Quarter 2023 Vir Biotechnology Inc 's Revenue quarter on quarter growth was below the average , that was still promising story, as the IV. Quarter improvement, transcends the -86.81% surge in the IV. Quarter a year ago

Within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Vir Biotechnology Inc 's Revenue growth quarter on quarter, overall rank is 17.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #5
Healthcare Sector #8
Overall #17
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #5
Healthcare Sector #8
Overall #17
Revenue Q/Q Growth Statistics
High Average Low
8860.93 % 837.39 % -97.12 %
(Jun 30 2021)  


VIR's IV. Quarter Q/Q Revenue Comment
Vir Biotechnology Inc achieved in the IV. Quarter 2023 below company average Revenue doubling of 535.87% quarter on quarter, to $ 16.79 millions.

IV. Quarter 2023 Vir Biotechnology Inc 's results appear to be a mixed bag, albeit lower than the ordinary increase of 837.39 %, yet it shows a quite acceleration relative to the -86.81% in the IV. Quarter 2022.

Within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Vir Biotechnology Inc 's Revenue growth quarter on quarter, overall rank is 17.


Vir Biotechnology Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 86.18 $ 118.80 $ 490.72 $ 446.30 $ 1,615.80
Y / Y Revenue Growth (TTM) -94.67 % -95.01 % -76.72 % -80.81 % 47.51 %
Year on Year Revenue Growth Overall Ranking # 126 # 9 # 3 # 6 # 12
Seqeuential Revenue Change (TTM) -27.46 % -75.79 % 9.95 % -72.38 % -32.08 %
Seq. Revenue Growth (TTM) Overall Ranking # 2072 # 576 # 1428 # 89 # 35




Cumulative Revenue growth Comment
Vir Biotechnology Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Vir Biotechnology Inc 's annual Revenue drop would be -94.67% year on year to $86 millions.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 9 to 126.

Revenue TTM Q/Q Growth Statistics
High Average Low
3102.57 %
578.85 %
-95.01 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 22
Healthcare Sector # 38
Overall # 126

Revenue TTM Y/Y Growth Statistics
High Average Low
3102.57 %
578.85 %
-95.01 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 257
S&P 500 # 2072
Cumulative Revenue growth Comment
Vir Biotechnology Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Vir Biotechnology Inc 's annual Revenue drop would be -94.67% year on year to $86 millions.

In the Healthcare sector 37 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 9 to 126.

Revenue TTM Q/Q Growth Statistics
High Average Low
3102.57 %
578.85 %
-95.01 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 22
Healthcare Sector # 38
Overall # 126

Revenue TTM Y/Y Growth Statistics
High Average Low
3102.57 %
578.85 %
-95.01 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 257
S&P 500 # 2072




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VIR's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for VIR's Competitors
Revenue Growth for Vir Biotechnology Inc 's Suppliers
Revenue Growth for VIR's Customers

You may also want to know
VIR's Annual Growth Rates VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roe VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Dividend Payout Ratio
VIR's Roa VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Aspira Women s Health Inc -1.07%$ -1.068 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc-2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Shl Telemedicine Ltd-3.26%$ -3.259 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Journey Medical Corporation-4.44%$ -4.441 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
American Shared Hospital Services-4.73%$ -4.725 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Psychemedics Corporation-5.24%$ -5.243 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Medicure Inc -5.94%$ -5.944 millions
Encision Inc -6.08%$ -6.083 millions
Biogen Inc -6.20%$ -6.199 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com